Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06161714Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of articaine in procedural pain (2 arms), sponsored by Riyadh Elm University. Primary endpoint: Pain measurement. Planned start Nov 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06161714.